Singapore and Silicon Valley-based biotech firm Engine Biosciences received $4 million from Polaris Partners last week. The investment is part of an $18 million Series A-3 financing.
Register now to enjoy 3 free articles per month,
or log in to continue reading.
Stay informed with complimentary articles each month
Gain access to our exclusive newsletters delivered directly to your inbox
Be the first to know about all our summits!
Already a Subscriber? Log in
